MT-RNR2 and major depressive disorder: As a functional validation of mt-Rnr2, treatment of mTBI-induced animals with an i.p. injection of humanin protected against learning and memory deficits and reversed numerous mTBI-perturbed pathways including metabolic depression, specifically in astrocytes, which may allow the neurons to maintain normal function and thus protect learning and memory.